Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Dr. Ian Walters
|
| gptkbp:country |
gptkb:Canada
gptkb:United_States |
| gptkbp:focus |
immuno-oncology
|
| gptkbp:foundedYear |
2013
|
| gptkbp:headquartersLocation |
gptkb:Toronto,_Canada
|
| https://www.w3.org/2000/01/rdf-schema#label |
Portage Biotech
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:products |
PORT-2
PORT-3 PORT-5 PORT-6 PORT-7 PORT-8 |
| gptkbp:specialty |
cancer therapeutics
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
PRTG
|
| gptkbp:website |
https://www.portagebiotech.com/
|
| gptkbp:bfsParent |
gptkb:Greg_Bailey
|
| gptkbp:bfsLayer |
7
|